Levels of adherence to coartem© in the routine treatment of uncomplicated malaria in children aged below five years, in Kenya

Iranian Journal of Public Health

Volumn 42, Issue 2, 2013, Pages 129-133

  Ogolla, Jared Otieno ^a   Ayaya, Samuel Omulando ^b   Otieno, Christina Agatha ^b  

^a MOUNT KENYA UNIVERSITY   (Kenya)

^b MOI UNIVERSITY   (Kenya)

Author keywords

Antimalaria; Artemisinin; Children; Non adherence; Therapies

Indexed keywords

EID: 84879174349     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. World Health Organization (WHO) (2001). Antimalarial Drug Combination Therapy. Re-port of a WHO Technical Consultation. WHO/CDS/RBM/ 2001: 35
2. Nosten F, van Vugt M, Price R (2000). Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in westernThailand: a prospective study. Lancet, 356: 297-302
3. Von Seidlein L, Milligan P, Pinder M (2000). Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, rando-mised, controlled trial. Lancet, 355: 352-357
4. Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ (2003). Prevention of increasing rates of treatment failure by combining sulfa-doxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J Infec Dis, 188: 1231-1238
5. Abdinasir A (2004). The difference between effi-cacy and effectiveness of antimalarial drugs in Kenya. Trop Med Int Hyg, 9 (7): 967-974
6. Fungladda W, Honrado ER, Thimasarn K (1998). Compliance with artesunate and qui-nine + tetracycline treatment of uncompli-cated falciparum malaria in Thailand. Bul of the WHO, 76 (1): 59-66
7. Bloland PB, Kachur SP, Williams HA (2003). Trends in antimalarial drug deployment in sub-Saharan Africa. J Exp Bio, 206: 3761 - 3769
8. Yepez MC, Zambrano D, Carrasco F, Yepez RF (2000). The factors associated with non-com-pliance with antimalarial treatment in Ecuadorian patients. Rev Cub de Med Trop, 52: 81-89
9. Gomes M, Wayling S, Pang L (1998). Interven-tions to improve the use of antimalarials in South East Asia. Bul of the WHO, 76 (1): 9-19
10. Haynes RB, Mc Donald H, Garg AX, Montague P (2002). Interventions for helping patients to follow prescriptions for medications. The Coch Database of Syst Rev 2002, Issue 1
11. White NJ (1998). Why is it that antimalarial drug treatments do not always work? Ann Trop Med Parasitol, 92 (4): 449-58
12. Fogg C, Bajunirwe F, Piola P (2004). Adherence to a six-dose regimen of artemether-Lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg, 5: 525-530
13. Pullar T (1991). Compliance with drug therapy. Brit J Clin Pharm, 32: 535 - 539
14. Bosworth HB (2006). Medication treatment adherence. In: Patient treatment adherence, concepts, interventions, and measurement. Lawrence Erl-baum Associates, Mahwah New Jersey, pp. 147-94
15. Depoortere E, Guthmann JP, Sipilanyambe N (2003). Adherence to the combination of sulfadoxine-pyrimethamine and artesunate in the Maheba Refugee Settlement, Zambia. Trop Med Int Hyg, 9: 62-67
16. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthmann JP (2004). Adherence to a combination of artemether and lumefantrine (Coartem®) in Kajo Keji, Southern Sudan. Am J Trop Med Hyg, 98: 635-637
17. Nshakira N, Kristensen M, Ssali F, Whyte SR (2002). Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Hyg, 7: 309-316
18. Chanda P, Sikaala CH, Kapelwa W, Moonga H, Njunju E, Macdonald M, Thea D, Hamer DH, Sipilanyambe N (2004). Assesment of the therapeutic efficacy of artemether-lumefantrine (Coartem®) and sulphadoxine-pyrimethamine (SP)- artesunate in Zambian children. Soc Trop Med Hyg, 53 (213): 7-11
19. Rugemalila JB, Lwanga CL, Kilama WL (2006). Sixth Malaria Day in 2006: How far have we come after Abuja Declaration? Mal J, 5: 102
20. Sattabongkot J, Tsuboi T, Zollner GB, Sirichaisinthop J, Cui L (2004). Plasmodium vi-vax transmission: chances for control? Trends Parasitol, 20:192-198.